CDH1 and neoplasm: Mandal et al [30], studied eleven HNSC cell lines and 50 primary tumors using western blot analysis as well as immunohistochemical, and functional techniques to assess the status of activated Src (p-Src), E-cadherin, and vimentin in both cell lines and tumor tissues and the results were correlated with patients’ clinicopathologic parameters.